Expression of B2 Receptor on Circulating CD34-Positive Cells and Outcomes of Myocardial Infarction

• Main Authors: Cong Fu, Yuhan Cao, Yuyu Yao, Shengxing Tang, Qun Fan, Yang Ling
• Format: Article
• Language: English
• Published: Hindawi Limited 2019-01-01
• Series: Disease Markers
• Online Access: http://dx.doi.org/10.1155/2019/7816438

Background. Bradykinin B2 receptor (B2R) is a widely expressed cell surface receptor. The relationship between B2R expression on circulating CD34+ cells and prognosis of myocardial infarction remains unknown. Methods. We analyzed the expression of B2R on circulating CD34-positive cells and plasma VEGF concentration in 174 myocardial infarction patients. All involved patients were divided into two groups: high B2R group and low B2R group according to the median B2R expression percentage. 48 months of follow-up was performed. The endpoints were heart failure and revascularization. Results. The plasma level of VEGF in the low B2R group is 67±12 pg/mL, whereas the high B2R group has significantly elevated VEGF levels of 145±27 pg/mL (P<0.001). The concentration of VEGF has correlated with expression of B2R (r=0.574, P<0.001). During the 48 months of follow-up, low expression of B2 receptor on circulating CD34-positive cells indicates the high incidence of heart failure (hazard ratio: 2.247; 95% confidence interval: 1.110-4.547; P=0.024) and revascularization (hazard ratio: 2.335; 95% confidence interval: 1.075-5.074; P=0.032). Kaplan-Meier survival analysis showed that the cumulative hazard of heart failure (P=0.014) and revascularization (P=0.032) has significant differences between low B2R and high B2R. Conclusion. Low expression of B2R on circulating progenitor cells indicated the poor outcomes of myocardial infarction.